Investor Overview

Corporate Profile

We are a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal (GI) and liver diseases.

Change: Volume:

Data Provided by Refinitiv. Minimum 15 minutes delayed.